Processa Pharmaceuticals Inc (PCSA)
2.09
-0.04
(-1.88%)
USD |
NASDAQ |
May 10, 16:00
2.09
0.00 (0.00%)
After-Hours: 20:00
Processa Pharmaceuticals Total Liabilities (Quarterly): 0.7975M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.7975M |
| September 30, 2023 | 0.9148M |
| June 30, 2023 | 0.9307M |
| March 31, 2023 | 2.290M |
| December 31, 2022 | 1.149M |
| September 30, 2022 | 1.364M |
| June 30, 2022 | 1.576M |
| March 31, 2022 | 1.064M |
| December 31, 2021 | 0.9784M |
| September 30, 2021 | 1.817M |
| June 30, 2021 | 1.896M |
| March 31, 2021 | 2.002M |
| December 31, 2020 | 2.275M |
| September 30, 2020 | 4.062M |
| June 30, 2020 | 3.418M |
| March 31, 2020 | 2.778M |
| December 31, 2019 | 2.871M |
| September 30, 2019 | 2.151M |
| June 30, 2019 | 2.804M |
| March 31, 2019 | 2.954M |
| December 31, 2018 | 2.780M |
| September 30, 2018 | 2.957M |
| June 30, 2018 | 3.131M |
| Date | Value |
|---|---|
| March 31, 2018 | 5.610M |
| December 31, 2017 | 2.610M |
| September 30, 2017 | 0.1153M |
| June 30, 2017 | 2.493M |
| March 31, 2017 | 2.439M |
| December 31, 2016 | 2.354M |
| September 30, 2016 | 2.285M |
| June 30, 2016 | 2.214M |
| March 31, 2016 | 2.165M |
| December 31, 2015 | 2.083M |
| September 30, 2015 | 2.116M |
| June 30, 2015 | 2.198M |
| March 31, 2015 | 1.841M |
| December 31, 2014 | 1.338M |
| September 30, 2014 | 2.783M |
| June 30, 2014 | 2.162M |
| March 31, 2014 | 1.878M |
| December 31, 2013 | 1.267M |
| September 30, 2013 | 1.466M |
| June 30, 2013 | 2.457M |
| March 31, 2013 | 1.449M |
| December 31, 2012 | 1.322M |
| September 30, 2012 | 1.296M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.7975M
Minimum
Dec 2023
4.062M
Maximum
Sep 2020
1.955M
Average
1.896M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| DIH Holding US Inc | -- |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.787M |
| Shareholders Equity (Quarterly) | 4.989M |